SI1737859T1 - Nova kristalinična oblika cian ciklopropil S S diazabiciklo nonan il fluor dihidro okso kinolin karboksilne kisline - Google Patents

Nova kristalinična oblika cian ciklopropil S S diazabiciklo nonan il fluor dihidro okso kinolin karboksilne kisline

Info

Publication number
SI1737859T1
SI1737859T1 SI200530913T SI200530913T SI1737859T1 SI 1737859 T1 SI1737859 T1 SI 1737859T1 SI 200530913 T SI200530913 T SI 200530913T SI 200530913 T SI200530913 T SI 200530913T SI 1737859 T1 SI1737859 T1 SI 1737859T1
Authority
SI
Slovenia
Prior art keywords
nonan
diazabicyclo
cyclopropyl
dihydro
oxo
Prior art date
Application number
SI200530913T
Other languages
English (en)
Inventor
Hubert Rast
Iris Heep
Alfons Grunenberg
Werner Hallenbach
Jordi Benet-Buchholz
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SI1737859T1 publication Critical patent/SI1737859T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SI200530913T 2004-04-01 2005-03-19 Nova kristalinična oblika cian ciklopropil S S diazabiciklo nonan il fluor dihidro okso kinolin karboksilne kisline SI1737859T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
EP05716236A EP1737859B1 (de) 2004-04-01 2005-03-19 Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0 nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
SI1737859T1 true SI1737859T1 (sl) 2010-03-31

Family

ID=34962324

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530913T SI1737859T1 (sl) 2004-04-01 2005-03-19 Nova kristalinična oblika cian ciklopropil S S diazabiciklo nonan il fluor dihidro okso kinolin karboksilne kisline

Country Status (32)

Country Link
US (1) US7977484B2 (sl)
EP (1) EP1737859B1 (sl)
JP (1) JP5190259B2 (sl)
KR (1) KR101217678B1 (sl)
CN (1) CN100591681C (sl)
AR (2) AR048099A1 (sl)
AT (1) ATE450536T1 (sl)
AU (1) AU2005231918B2 (sl)
BR (1) BRPI0509529B8 (sl)
CA (1) CA2561635C (sl)
CY (2) CY1109762T1 (sl)
DE (3) DE102004015981A1 (sl)
DK (1) DK1737859T3 (sl)
ES (1) ES2335899T3 (sl)
GT (1) GT200500043A (sl)
HK (1) HK1104537A1 (sl)
HR (1) HRP20100097T1 (sl)
IL (1) IL178353A (sl)
MY (1) MY140998A (sl)
NO (1) NO337279B1 (sl)
NZ (1) NZ550226A (sl)
PE (1) PE20060170A1 (sl)
PL (1) PL1737859T3 (sl)
PT (1) PT1737859E (sl)
RU (1) RU2383543C2 (sl)
SI (1) SI1737859T1 (sl)
SV (1) SV2006002070A (sl)
TW (1) TWI350755B (sl)
UA (1) UA84329C2 (sl)
UY (1) UY28828A1 (sl)
WO (1) WO2005097789A1 (sl)
ZA (1) ZA200608072B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
PE20191462A1 (es) 2017-02-13 2019-10-16 Bayer Animal Health Gmbh Composicion liquida que contiene pradofloxacina
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707606B1 (pt) 1996-02-23 2010-08-10 ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem.
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
BRPI0509529A (pt) 2007-09-18
KR101217678B1 (ko) 2013-01-02
US20080125458A1 (en) 2008-05-29
AR105177A2 (es) 2017-09-13
US7977484B2 (en) 2011-07-12
ATE450536T1 (de) 2009-12-15
CY1109762T1 (el) 2014-09-10
DE502005008620D1 (de) 2010-01-14
ZA200608072B (en) 2008-01-08
JP5190259B2 (ja) 2013-04-24
SV2006002070A (es) 2006-03-15
ES2335899T3 (es) 2010-04-06
CN1938304A (zh) 2007-03-28
TW200602053A (en) 2006-01-16
HK1104537A1 (en) 2008-01-18
CN100591681C (zh) 2010-02-24
PT1737859E (pt) 2010-02-03
AU2005231918B2 (en) 2011-05-12
BRPI0509529B8 (pt) 2021-05-25
RU2006138362A (ru) 2008-05-10
DE122011100055I1 (de) 2012-03-15
EP1737859B1 (de) 2009-12-02
IL178353A (en) 2011-08-31
AU2005231918A1 (en) 2005-10-20
HRP20100097T1 (hr) 2010-04-30
TWI350755B (en) 2011-10-21
NZ550226A (en) 2009-11-27
NO337279B1 (no) 2016-02-29
CA2561635A1 (en) 2005-10-20
DE102004015981A1 (de) 2005-10-20
AR048099A1 (es) 2006-03-29
DK1737859T3 (da) 2010-04-06
BRPI0509529B1 (pt) 2019-05-21
GT200500043A (es) 2006-02-17
UY28828A1 (es) 2005-11-30
NO20064988L (no) 2006-10-31
PE20060170A1 (es) 2006-04-13
WO2005097789A1 (de) 2005-10-20
CA2561635C (en) 2012-10-16
KR20070014157A (ko) 2007-01-31
RU2383543C2 (ru) 2010-03-10
PL1737859T3 (pl) 2010-04-30
JP2007530614A (ja) 2007-11-01
MY140998A (en) 2010-02-12
CY2011018I1 (el) 2016-12-14
UA84329C2 (en) 2008-10-10
EP1737859A1 (de) 2007-01-03
IL178353A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
ZA201205505B (en) Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cfms inhibitors
HK1104031A1 (en) Benzimidazolone carboxylic acid derivatives
AP2007004001A0 (en) Novel dicarboxylic acid derivatives
ZA200801890B (en) Novel crystalline form of a pyridazino (4, 5-B) indole derivative
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
HK1104537A1 (en) Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8- diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
WO2006134491A3 (en) New crystalline form of moxifloxacin hydrochloride and process for its preparation
PT1805316E (pt) Processo para a preparação das formas enantioméricas de derivados de ácido cis-3-hidroxiciclo-hexanocarboxílico utilizando hidrolases
ZA200409433B (en) Process for the preparation of carboxylic acid esters.
BRPI0810192C1 (pt) aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diaza-espiro [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.
PL378119A1 (pl) Kwasy karboksylowe
TWI347936B (en) Method of producing 帢,帣-unsaturated carboxylic acid compounds
IL142695A0 (en) Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
WO2006061380A3 (en) SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION
HK1045158A1 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s, 6s, 2,8-diazabicyclo-(4.3.0.)nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
EP1906958A4 (en) PYRAZOLO [3,4-B] PYRIDIN-2-YL] -BENZOIC DERIVATIVES AS HIV INTEGRASE INHIBITORS
PL347799A1 (en) Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
IL142696A0 (en) Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
NO20044629L (no) Fremgangsmate til fremstilling av sure salter av gemifloksasin.
ZA200507741B (en) Novel intermediate for the preparation of therapeutically active imidazopyridines
IL177701A0 (en) Method for producing 1,5-diphenylpyrazole carboxylic acid derivatives
AP2006003847A0 (en) Benzhimidazolone carboxylic acid derivatives
FI20021510A (fi) Karboksyylihapon suolojen valmistusprosessi
GB0703687D0 (en) Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16al-pha-methyl-3-oxo-17alpha-propionyloxy-androsta-1, 4-diene-17beta-carbyoxylic acid